Delong Liu

Delong Liu

Auto-generated profile, based on publicly available information

Delong Liu

Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Zhengzhou Industrial Technology Research Institute, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2014 in Organic Letters
Verified
Journal Article
Closed access
XHXiaohong Huo
Xiaohong Huo
MQMao Quan
Mao Quan
GYGuoqiang Yang
Guoqiang Yang
XZXiaohu Zhao
Xiaohu Zhao
DLDelong Liu
Delong Liu
WZWanbin Zhang
Wanbin Zhang

12 October 2015 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
JWJianxia Wang
Jianxia Wang
YWYanzhao Wang
Yanzhao Wang
DLDelong Liu
Delong Liu
WZWanbin Zhang
Wanbin Zhang

17 February 2017 in Organic Letters
Verified
Journal Article
Closed access
QYQianjia Yuan
Qianjia Yuan
DLDelong Liu
Delong Liu
WZWanbin Zhang
Wanbin Zhang

12 November 2015 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
QAQianjin An
Qianjin An
JSJiefeng Shen
Jiefeng Shen
NBNicholas Butt
Nicholas Butt
DLDelong Liu
Delong Liu
YLYangang Liu
Yangang Liu
WZWanbin Zhang
Wanbin Zhang

18 October 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YXYunnan Xu
Yunnan Xu
YLYicong Luo
Yicong Luo
JYJianxun Ye
Jianxun Ye
YDYu Deng
Yu Deng
DLDelong Liu
Delong Liu
WZWanbin Zhang
Wanbin Zhang

13 November 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
YMYujie Ma
Yujie Ma
JLJing Li
Jing Li
JYJianxun Ye
Jianxun Ye
DLDelong Liu
Delong Liu
WZWanbin Zhang
Wanbin Zhang
Chiral chromanols and their derivatives have been synthesized via a RuPHOX–Ru catalyzed asymmetric hydrogenation of chromones in high yields, >20 : 1 drs and with up to 99.9% ee. Control experiments show that the reaction undergoes two sequential asymmetric hydrogenation steps of the CC and CO double bonds. The reaction could be performed on a gram-scale with a relatively low catalyst loading (up to 1000 S/C), and the resulting products can be transformed to several biologically active compounds.